Yuko Kimura, Ph.D. Mba Email & Phone Number

New York, NY, US

• As a subject matter expert, provide research analysis and consolidated strategic recommendations related to the healthcare business, policy-making, research, and development for the firm’s Japanese clients who are.
• Responsible for researching and advising Japanese clients strategically about practices, policy, and scientific advancements in healthcare and biotech sectors in the US. Projects will include investigating and advising.
• Research results and recommendations are used for various Japanese companies’ internal and public reporting, for example, white papers and other official communications and reports for government-related bodies.

Tokyo, JP

• Managed internal and external R&D Communications (portal site, town halls, corporate website, senior leaders’ messaging, mass media interface); successfully structured stakeholder R&D Communications network.
• Responsible for learning and change management; for example, created, managed, and conducted research initiatives during COVID-19 to increase productivity of R&D staff working from home; strategized future best.
• Strategic activities improved the efficiency of R&D senior leadership meetings, transparency, increased learning, operational excellence, and enhanced employee experience, helping shorten launch time to accelerate.
• Led efficient strategic operations of global R&D senior leadership meetings as the coordination office member to accelerate more transparent and faster decision-making.
• Drove R&D risk management strategies, including communicating to enable planning and implementation of business continuity plan; helped revise BCP with COVID-19 protocols, as well as revisions necessitated by the loss.

Basking Ridge, NJ, US

• Promoted R&D 2025 vision development and facilitated tracking to key R&D workstreams as chief of staff for the global head of R&D and a senior leadership team member. Led a seven-member cross-functional and.
• Prioritized business cases for global R&D in cooperation with Tokyo HQ (i.e., R&D communications, employee engagement, employee training, learning events). Designed and promoted multiple projects to leverage.
• Led a cross-functional and cross-regional team designing and executing a series of business onboarding training sessions for newly hired R&D colleagues (once a month for around 20 colleagues each). Helped improve.
• Created and oversaw a first-of-its-kind, internal, interactive employees’ learning event, the Science Symposium in 2017 and 2018, which showcased 140 posters and scientific discussions. Implemented and received.
• Supported the global RD head for his external activities in the Pharmaceutical Research and Manufacturers of America, gaining a broad global perspective of policy making and other processes between the pharmaceutical.

Tokyo, JP

• Oversaw the entire project management of global marketing strategies and alliance management, budget/resource management and tactics for Olmesartan, an original anti-hypertension medicine, collaborating with 30.
• Led several projects for the global, cross-functional, anti-hypertension medical and communication programs, including managing a 10-member franchise teams to maximize the value of the entire franchise.
• Led the educational program development and execution for 30 global key opinion leaders on hypertension, ‘The Hypertension Masterclass,’ which was certified by the European Board for Accreditation in Cardiology.

• Strategized and implemented the overall global corporate social responsibility strategy, programs, sustainability reporting, and internal/external stakeholder communications.
• Improved the company’s position and bettered transparency efforts for external stakeholder communications in the Access to Medicine Index 2016 supported by the Bill & Melinda Gates Foundations and the Dow Jones.

• Initiated and oversaw the clinical development management system of performance evaluation, hiring, training, and budget tracking among R&D functions in Shanghai, Beijing, Taipei, Hong Kong, Thailand, Seoul, and.
• Created a successful series of Women’s Leadership Initiatives in Japan HQ.
• Completed Clinical Research Associate (CRA) training and received the CRA certificate in Japan.

Contributed to maximizing the $3B ‘levofloxacin’ (anti-infective agent) franchise brand sales and steered the global marketing project strategy and tactics in cooperation with Johnson & Johnson, Aventis, and GlaxoSmithKline, and business partners in Latin Americas, Turkey, and Asian countries. Contributed to maximizing the $700M oncology product.

• Implemented several Phase 4 studies of cardiovascular, wound healing, orthopedic, and hematology products in a regulated environment by GPMSP.
• Published Phase 4 study results in international congresses and academic journals.
• Contributed to several process quality improvement projects, such as 1. the package insert development process, 2. collaboration between Medical Affairs/ RD/ Sales & Marketing, and 3. phase 4 study database system.

Doctor Of Social Science (Dsocsci, Equivalent To Ph.D.), School Of Business

Global Agenda

Master Of Business Administration (M.B.A.) With Merit, School Of Management

Bachelor Of Science In Pharmacy - Bsc, Pharmaceutical Chemistry

Education record